Relvar Ellipta is an ICS/LABA combination for the treatment of asthma and COPD  . Relvar is the only ICS/LABA which is one inhalation, once daily which delivers 24 hours of continuous efficacy. For information about the differing licensed doses in asthma and COPD, please see Indications page.
*SMC= Scottish Medicines Consortium
ǂ AWMSG= All Wales Medicines Strategy Group